Similar articles

• Assessment of anthrax vaccination data in the Defense Medical Surveillance System, 1998-2004.

  Payne DC, Rose CE Jr, Aranas A, Zhang Y, Tolentino H, Weston E, McNeil MM, Ruscio B. Payne DC, et al. Pharmacoepidemiol Drug Saf. 2007 Jun;16(6):605-11. doi: 10.1002/pds.1395. Pharmacoepidemiol Drug Saf. 2007. PMID: 17437247
• A comparative assessment of immunization records in the Defense Medical Surveillance System and the Vaccine Adverse Event Reporting System.

  McNeil MM, Ma G, Aranas A, Payne DC, Rose CE Jr. McNeil MM, et al. Vaccine. 2007 Apr 30;25(17):3428-36. doi: 10.1016/j.vaccine.2006.12.044. Epub 2007 Jan 26. Vaccine. 2007. PMID: 17258846
• Anthrax vaccination and risk of optic neuritis in the United States military, 1998-2003.

  Payne DC, Rose CE Jr, Kerrison J, Aranas A, Duderstadt S, McNeil MM. Payne DC, et al. Arch Neurol. 2006 Jun;63(6):871-5. doi: 10.1001/archneur.63.6.871. Arch Neurol. 2006. PMID: 16769869
• Safety of anthrax vaccine: an expanded review and evaluation of adverse events reported to the Vaccine Adverse Event Reporting System (VAERS).

  Sever JL, Brenner AI, Gale AD, Lyle JM, Moulton LH, Ward BJ, West DJ. Sever JL, et al. Pharmacoepidemiol Drug Saf. 2004 Dec;13(12):825-40. doi: 10.1002/pds.936. Pharmacoepidemiol Drug Saf. 2004. PMID: 15386719 Review.
• Safety of anthrax vaccine: a review by the Anthrax Vaccine Expert Committee (AVEC) of adverse events reported to the Vaccine Adverse Event Reporting System (VAERS).

  Sever JL, Brenner AI, Gale AD, Lyle JM, Moulton LH, West DJ; Anthrax Vaccine Export Committee. Sever JL, et al. Pharmacoepidemiol Drug Saf. 2002 Apr-May;11(3):189-202. doi: 10.1002/pds.712. Pharmacoepidemiol Drug Saf. 2002. PMID: 12051118 Review.